In addition to immunosuppressive effects, MDSCs influence the remodeling of the tumor microenvironment and tumor angiogenesis through inducing the production of VEGF, bFGF, Bv8, and MMP9, thereby promoting tumor progression (Shojaei et al., 2009; Tartour et al., 2011). This evidence concerns the gene PROK2 and neoplasm.